8-89984563-G-T
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4_StrongBP6
The NM_002485.5(NBN):c.-2C>A variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000992 in 1,612,992 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_002485.5 5_prime_UTR
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NBN | NM_002485.5 | c.-2C>A | 5_prime_UTR_variant | Exon 1 of 16 | ENST00000265433.8 | NP_002476.2 | ||
NBN | NM_001024688.3 | c.-298C>A | 5_prime_UTR_variant | Exon 1 of 17 | NP_001019859.1 | |||
NBN | XM_011517046.2 | c.-2C>A | 5_prime_UTR_variant | Exon 1 of 11 | XP_011515348.1 | |||
NBN | XM_047421796.1 | c.-2C>A | 5_prime_UTR_variant | Exon 1 of 10 | XP_047277752.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000525 AC: 8AN: 152252Hom.: 1 Cov.: 33
GnomAD3 exomes AF: 0.0000123 AC: 3AN: 244888Hom.: 0 AF XY: 0.0000149 AC XY: 2AN XY: 133794
GnomAD4 exome AF: 0.00000548 AC: 8AN: 1460740Hom.: 0 Cov.: 30 AF XY: 0.00000413 AC XY: 3AN XY: 726738
GnomAD4 genome AF: 0.0000525 AC: 8AN: 152252Hom.: 1 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74380
ClinVar
Submissions by phenotype
not specified Uncertain:2
- -
Variant summary: NBN c.-2C>A is located in the untranslated mRNA region upstream of the initiation codon. The variant allele was found at a frequency of 1.2e-05 in 244888 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.-2C>A has been reported in the literature in at-least one individual undergoing clinical genetic testing based on a history of Lynch syndrome-associated cancer and/or polyps (Yurgelun_2015). This report does not provide unequivocal conclusions about association of the variant with Nijmegen Breakage Syndrome and/or NBN related cancer predisposition syndrome. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Four clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. Multiple laboratories reported the variant with conflicting assessments and limited evidence (VUS, n=2, likely benign, n=2). Based on the evidence outlined above, the variant was classified as uncertain significance. -
Microcephaly, normal intelligence and immunodeficiency Uncertain:2
This variant occurs in a non-coding region of the NBN gene. It does not change the encoded amino acid sequence of the NBN protein. This variant is present in population databases (rs202104448, gnomAD 0.0009%). This variant has not been reported in the literature in individuals affected with NBN-related conditions. ClinVar contains an entry for this variant (Variation ID: 142021). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
- -
not provided Uncertain:1Benign:1
- -
This variant is associated with the following publications: (PMID: 25980754, 24168161) -
Hereditary cancer-predisposing syndrome Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at